Oncologists share the number-one sign of lymphoma that you shouldn't ignore, plus other symptoms that may signal this rare ...

LUT014 gel significantly reduces acne-like rashes from anti-EGFR therapies in colorectal cancer patients, improving quality of life. The phase 2 trial showed 70% improvement with high-dose gel, ...

NEW YORK (Reuters Health) - The development of a skin rash in patients with pancreatic cancer or lung cancer treated with Tarceva is a strong indication that the drug is working, report researchers ...

A research team from the UCLA Health Jonsson Comprehensive Cancer Center, the University of Texas MD Anderson Cancer Center, and collaborators have demonstrated that a novel topical BRAF inhibitor gel ...

ATR04-484 is a live biotherapeutic product targeting EGFR inhibitor-associated rashes in cancer patients, containing a modified Staphylococcus epidermidis strain. EGFR inhibitors, used in treating ...

Please provide your email address to receive an email when new articles are posted on . ATR-04 has received a fast track designation from the FDA for epidermal growth factor receptor ...

Colon cancer, also called colorectal cancer, mainly affects the large intestine and rectum. It is among the most common cancers in the UK and globally, impacting thousands of lives each year. While ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a novel topical BRAF inhibitor gel called LUT014 ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a novel topical BRAF inhibitor gel called LUT014 ...

Michelle Smith was told she had eczema as a teenager, but as the years went on her skin became 'so much worse' - until ...

Because of the now ubiquitous use of immunotherapies in cancer treatment, community dermatologists have an increasingly important role in identifying and often managing chronic adverse events (AEs) ...